Cargando…

Synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on PC12 cells

BACKGROUND: The loss of cholinergic neurotransmission in Alzheimer's disease (AD) patients' brain is accompanied by a reduced concentration of Acetylcholine (ACh) within synaptic clefts. Thus, the use of acetylcholinesterase inhibitors (AChEIs) to block the cholinergic degradation of ACh i...

Descripción completa

Detalles Bibliográficos
Autores principales: Taheri, Maryam, Aslani, Samira, Ghafouri, Hossein, Mohammadi, Asadollah, Akbary Moghaddam, Vaha, Moradi, Nastarn, Naeimi, Hananeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864858/
https://www.ncbi.nlm.nih.gov/pubmed/35193649
http://dx.doi.org/10.1186/s13065-022-00799-w
_version_ 1784655538013863936
author Taheri, Maryam
Aslani, Samira
Ghafouri, Hossein
Mohammadi, Asadollah
Akbary Moghaddam, Vaha
Moradi, Nastarn
Naeimi, Hananeh
author_facet Taheri, Maryam
Aslani, Samira
Ghafouri, Hossein
Mohammadi, Asadollah
Akbary Moghaddam, Vaha
Moradi, Nastarn
Naeimi, Hananeh
author_sort Taheri, Maryam
collection PubMed
description BACKGROUND: The loss of cholinergic neurotransmission in Alzheimer's disease (AD) patients' brain is accompanied by a reduced concentration of Acetylcholine (ACh) within synaptic clefts. Thus, the use of acetylcholinesterase inhibitors (AChEIs) to block the cholinergic degradation of ACh is a promising approach for AD treatment. In the present study, a series of 2-chloro-3-hydrazinopyrazine derivatives (CHP1-5) were designed, synthesized, and biologically evaluated as potential multifunctional anti-AD agents. METHODS: In addition, the chemical structures and purity of the synthesized compounds were elucidated through using IR, (1)H and (13)C NMR, and elemental analyses. Further, the intended compounds were assessed in vitro for their AChE inhibitory and neuroprotective effects. Furthermore, DPPH, FRAP and ABTS assays were utilized to determine their antioxidant activity. The statistical analysis was performed using one-way ANOVA. RESULTS: Based on the results, CHP4 and CHP5 exhibited strong AChE inhibitory effects with the IC(50) values of 3.76 and 4.2 µM compared to the donepezil (0.53 µM), respectively. The study examined the effect and molecular mechanism of CHP4 on the Ab1–42-induced cytotoxicity in differentiated PC12 cells. At concentrations of 0–100 μM, CHP4 was non-toxic in PC12. Additionally, Ab1–42 significantly stimulated tau hyperphosphorylation and induced differentiated PC12 cell death. Further, CHP4 resulted in diminishing the Ab1–42-induced toxicity in PC12 cell significantly. CHP4 at 30 μM concentration significantly increased the Ab1–42-induced HSP70 expression and decreased tau hyperphosphorylation. CONCLUSIONS: According to the results of our studies CHP4 can be considered as safe and efficient AChEI and employed as a potential multifunctional anti-AD agent. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-022-00799-w.
format Online
Article
Text
id pubmed-8864858
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88648582022-02-28 Synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on PC12 cells Taheri, Maryam Aslani, Samira Ghafouri, Hossein Mohammadi, Asadollah Akbary Moghaddam, Vaha Moradi, Nastarn Naeimi, Hananeh BMC Chem Research Article BACKGROUND: The loss of cholinergic neurotransmission in Alzheimer's disease (AD) patients' brain is accompanied by a reduced concentration of Acetylcholine (ACh) within synaptic clefts. Thus, the use of acetylcholinesterase inhibitors (AChEIs) to block the cholinergic degradation of ACh is a promising approach for AD treatment. In the present study, a series of 2-chloro-3-hydrazinopyrazine derivatives (CHP1-5) were designed, synthesized, and biologically evaluated as potential multifunctional anti-AD agents. METHODS: In addition, the chemical structures and purity of the synthesized compounds were elucidated through using IR, (1)H and (13)C NMR, and elemental analyses. Further, the intended compounds were assessed in vitro for their AChE inhibitory and neuroprotective effects. Furthermore, DPPH, FRAP and ABTS assays were utilized to determine their antioxidant activity. The statistical analysis was performed using one-way ANOVA. RESULTS: Based on the results, CHP4 and CHP5 exhibited strong AChE inhibitory effects with the IC(50) values of 3.76 and 4.2 µM compared to the donepezil (0.53 µM), respectively. The study examined the effect and molecular mechanism of CHP4 on the Ab1–42-induced cytotoxicity in differentiated PC12 cells. At concentrations of 0–100 μM, CHP4 was non-toxic in PC12. Additionally, Ab1–42 significantly stimulated tau hyperphosphorylation and induced differentiated PC12 cell death. Further, CHP4 resulted in diminishing the Ab1–42-induced toxicity in PC12 cell significantly. CHP4 at 30 μM concentration significantly increased the Ab1–42-induced HSP70 expression and decreased tau hyperphosphorylation. CONCLUSIONS: According to the results of our studies CHP4 can be considered as safe and efficient AChEI and employed as a potential multifunctional anti-AD agent. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-022-00799-w. Springer International Publishing 2022-02-22 /pmc/articles/PMC8864858/ /pubmed/35193649 http://dx.doi.org/10.1186/s13065-022-00799-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Taheri, Maryam
Aslani, Samira
Ghafouri, Hossein
Mohammadi, Asadollah
Akbary Moghaddam, Vaha
Moradi, Nastarn
Naeimi, Hananeh
Synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on PC12 cells
title Synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on PC12 cells
title_full Synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on PC12 cells
title_fullStr Synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on PC12 cells
title_full_unstemmed Synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on PC12 cells
title_short Synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on PC12 cells
title_sort synthesis, in vitro biological evaluation and molecular modelling of new 2-chloro-3-hydrazinopyrazine derivatives as potent acetylcholinesterase inhibitors‏ on pc12 cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864858/
https://www.ncbi.nlm.nih.gov/pubmed/35193649
http://dx.doi.org/10.1186/s13065-022-00799-w
work_keys_str_mv AT taherimaryam synthesisinvitrobiologicalevaluationandmolecularmodellingofnew2chloro3hydrazinopyrazinederivativesaspotentacetylcholinesteraseinhibitorsonpc12cells
AT aslanisamira synthesisinvitrobiologicalevaluationandmolecularmodellingofnew2chloro3hydrazinopyrazinederivativesaspotentacetylcholinesteraseinhibitorsonpc12cells
AT ghafourihossein synthesisinvitrobiologicalevaluationandmolecularmodellingofnew2chloro3hydrazinopyrazinederivativesaspotentacetylcholinesteraseinhibitorsonpc12cells
AT mohammadiasadollah synthesisinvitrobiologicalevaluationandmolecularmodellingofnew2chloro3hydrazinopyrazinederivativesaspotentacetylcholinesteraseinhibitorsonpc12cells
AT akbarymoghaddamvaha synthesisinvitrobiologicalevaluationandmolecularmodellingofnew2chloro3hydrazinopyrazinederivativesaspotentacetylcholinesteraseinhibitorsonpc12cells
AT moradinastarn synthesisinvitrobiologicalevaluationandmolecularmodellingofnew2chloro3hydrazinopyrazinederivativesaspotentacetylcholinesteraseinhibitorsonpc12cells
AT naeimihananeh synthesisinvitrobiologicalevaluationandmolecularmodellingofnew2chloro3hydrazinopyrazinederivativesaspotentacetylcholinesteraseinhibitorsonpc12cells